Phreesia (PHR) FCF Margin (2018 - 2026)

Phreesia (PHR) posted FCF Margin of 15.8% for Q2 2026, down 35.43% sequentially from 24.46% in Q1 2026, and up 395.0% YoY from 3.19% in Q2 2025.

Phreesia (PHR) FCF Margin (2018 - 2026) Analysis & Trends

Phreesia has reported FCF Margin for 9 years, with the latest figure at 15.8% in Q2 2026.

Quarterly FCF Margin rose 395.0% year-over-year to 15.8% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 15.18% (up 428.0% YoY) and the FY2026 annual result came in at 13.63%, up 635.0% from the prior year.
FCF Margin eased to 15.8% in Q2 2026 per PHR's latest filing, from 24.46% in the prior quarter.
Over five years, FCF Margin peaked at 24.46% in Q1 2026 and troughed at 58.2% in Q1 2022.
A 5-year average of 9.14% and a median of 3.16% in 2024 frame the typical range for FCF Margin.
The sharpest annual moves came in 2022 and 2023: FCF Margin tumbled 5222 bps in 2022, then soared 3602 bps in 2023.
Over 5 years, FCF Margin stood at 46.09% in 2022, then surged by 78 bps to 10.06% in 2023, then soared by 148 bps to 4.84% in 2024, then surged by 107 bps to 10.03% in 2025, then jumped by 57 bps to 15.8% in 2026.
According to Business Quant data, FCF Margin over the past three periods registered 15.8%, 24.46%, and 10.03% for Q2 2026, Q1 2026, and Q4 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn	127.46%
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn	0.38%
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn	23.01%
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn	10.19%
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn	46.84%
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn	-27.00%
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn	13.54%
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn	25.33%
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn	-
10	Phreesia	758.43 Mn	682.03 Mn	113.28 Mn	15.80%

Download Data